:::

學術成果

:::
搜尋
年至

月至


  • 關鍵字搜尋
  • 第 1 頁 / 共 10 頁
    1. [上一頁]
    2. [1]
    3. 2
    4. 3
    5. 4
    6. ...
    7. 8
    8. 9
    9. 10
    10. [下一頁]
    期刊論文
    學年度著作著作人
    102Brown JS, Petronis KR, Bate A, Zhang F, Dashevsky I, Kulldorff M, Avery TR, Davis RL, Chan KA, Andrade SE, Boudreau D, Gunter MJ, Herrinton L, Pawloski PA, Raebel MA, Roblin D, Smith D, Reynolds R. ,2013,Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. ,Pharmaceutics,5,1,pp179-200 (SCI)陳建煒
    102Funch D, Holick C, Velentgas P, Clifford R, Wahl PM, McMahill-Walraven C, Gladowski P, Platt R, Amato A, Chan KA.,2013,Algorithms for identification of Guillain Barré Syndrome in claims databases. ,Vaccine,31,12,pp2075-2079 (SCI)陳建煒
    102Kulldorff M, Dashevsky I, Avery T, Chan KA, Davis RL, Graham D, Platt R, Andrade SE, Boudreau D, Gunter MJ, Herrinton LJ, Pawloski P, Raebel MA, Roblin D, Brown JS. ,2013,Drug safety data mining with a tree-based SCAN statistic.,Pharmacoepidemiology and Drug Safety,22,5,pp517-523 (SCI)陳建煒
    102Dong Y-H, Chang C-H, Shau W-Y, Kuo RN, Lai M-S, Chan KA. ,2013,Development and validation of a pharmacy-based comorbidity measure in a population-based automated healthcare database. ,Pharmacotherapy,33,2,pp123-136 (SCI)陳建煒
    101Sequist LV, Yang JC*, Yamamoto N, O”Byrne K, Hirsh V, Mok T, Geater SL, Pavlov SO, Tsai CM, Boyer M, Su WC, Bennouna J, Kato T, Gorbunova V, Lee KH, Shah R, Massey D, Zazulina V, Shahidi M and Schuler M. ,2013,Phase III study of Afatinib or Cisplatin/Pemetrexed in Metastatic Lung Adenocarcinoma Patients with Epidermal Growth Factor Receptor Mutations.(accepted) ,Journal of Clinical Oncology (SCI)楊志新
    101Shao YY, Shau WY, Lin ZZ, Chen HM, Kuo R, Yang JC*, Lai MS*.,2013,Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer., Eur J Cancer. (SCI)楊志新
    101Yang JC.,2012,Small-Cell Lung Cancer Treatment: Where is the Target?(editorial),J Thorac Oncol.,7,9,pp1327-1328 (SCI)楊志新
    101Ahn MJ, Yang JC, Liang J, Kang JH, Xiu Q, Chen YM, Blair JM, Peng G, Linn C, Orlando M.,2012,Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer. ,Lung Cancer. ,77,2,pp346-352 (SCI)楊志新
    101Ohashi K, Sequist LV, Arcila ME, Moran T, Chmielecki J, Lin YL, Pan Y, Wang L, de Stanchina E, Shien K, Aoe K, Toyooka S, Kiura K, Fernandez-Cuesta L, Fidias P, Yang JC, Miller VA, Riely GJ, Kris MG, Engelman JA, Vnencak-Jones CL, Dias-Santagata D, Ladanyi M, Pao W.,2012,Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. ,Proc Natl Acad Sci USA.,109,31,ppE2127-E2133 (SCI)楊志新
    101Lin ZZ, Shau WY, Shao YY, Yang YY, Kuo RN, Yang JC*, Lai MS.,2012,Survival Following Surgery with or without Adjuvant Chemotherapy for Stage I-IIIA Non-Small Cell Lung Cancer: An East Asian Population-Based Study.[Epub ahead of print] ,Oncologist. (SCI)楊志新
    第 1 頁 / 共 10 頁
    1. [上一頁]
    2. [1]
    3. 2
    4. 3
    5. 4
    6. ...
    7. 8
    8. 9
    9. 10
    10. [下一頁]